Market Research Logo

Global Malignant Mesothelioma Therapeutics Market 2019-2023

Global Malignant Mesothelioma Therapeutics Market 2019-2023

Global Malignant Mesothelioma Therapeutics Market: About this market

A malignant mesothelioma is a rare form of cancer affecting the thin tissue known as mesothelium that lines the lung, chest wall, and abdomen. Technavio’s malignant mesothelioma therapeutics market analysis considers sales from both chemotherapy and other therapeutics. Our analysis also considers the sales of malignant mesothelioma therapeutics in Asia, Europe, North America, and ROW. In 2018, the chemotherapy segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as growing demand for chemotherapy will play a significant role in the chemotherapy segment to maintain its market position. Also, our global malignant mesothelioma therapeutics report also looks at factors such as increasing adoption of combination therapies, increasing use of asbestos for commercial purposes, and special regulatory designations. However, a long latency period of malignant mesothelioma, lack of disease-specific biomarkers in earlier stages, and development and approval of advanced devices for cancer treatment may hamper the growth of the malignant mesothelioma therapeutics industry over the forecast period.

Global Malignant Mesothelioma Therapeutics Market: Overview

Increasing the use of asbestos for commercial purposes

Exposure to asbestos is the primary risk factor for malignant mesothelioma. The significant rise in the use of asbestos in commercial purposes such as building materials, machines, and transport vehicles is causing this disease in the workers due to regular exposure. The extensive use of asbestos for commercial purpose will lead to the expansion of the global malignant mesothelioma therapeutics market at a CAGR of almost 7% during the forecast period.

Increasing awareness of malignant mesothelioma

The increasing incidence and prevalence of malignant mesothelioma across the world leading to an increasing need for awareness initiatives to diagnose and treat the disease at earlier stages. Many organizations are spreading awareness about the disease and advising workers who are regularly exposed to asbestos to undergo regular screening of malignant mesothelioma, which may prevent the disease progression to advanced stages. This increasing awareness is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global malignant mesothelioma therapeutics market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of several major players, the global malignant mesothelioma therapeutics market is fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading malignant mesothelioma therapeutics companies, that include Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., and Pfizer Inc.

Also, the malignant mesothelioma therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.


Companies Mentioned

Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., and Pfizer Inc.

  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global oncology therapeutics market
      • Table Segments of global oncology therapeutics market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by product
    • Table Product - Market share 2018-2023 (%)
    • Comparison by product
      • Table Comparison by product
    • Chemotherapy - Market size and forecast 2018-2023
      • Table Chemotherapy - Market size and forecast 2018-2023 ($ millions)
      • Table Chemotherapy - Year-over-year growth 2019-2023 (%)
    • Other therapeutics - Market size and forecast 2018-2023
      • Table Other therapeutics - Market size and forecast 2018-2023 ($ millions)
      • Table Other therapeutics - Year-over-year growth 2019-2023 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table North America - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in North America
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Europe
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Asia - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Asia
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in ROW
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Drug designations
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
    • Increasing awareness of malignant mesothelioma
    • Development of novel therapies
    • Reimbursement policies for chemotherapy
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Bristol-Myers Squibb Co.
      • Table Bristol-Myers Squibb Co. - Vendor overview
      • Table Bristol-Myers Squibb Co. - Product segments
      • Table Bristol-Myers Squibb Co. - Organizational developments
      • Table Bristol-Myers Squibb Co. - Geographic focus
      • Table Bristol-Myers Squibb Co. - Key offerings
      • Table Bristol-Myers Squibb Co. - Key customers
    • Eli Lilly and Co.
      • Table Eli Lilly and Co. - Vendor overview
      • Table Eli Lilly and Co. - Business segments
      • Table Eli Lilly and Co. - Organizational developments
      • Table Eli Lilly and Co. - Geographic focus
      • Table Eli Lilly and Co. - Segment focus
      • Table Eli Lilly and Co. - Key offerings
      • Table Eli Lilly and Co. - Key customers
    • F. Hoffmann-La Roche Ltd.
      • Table F. Hoffmann-La Roche Ltd. - Vendor overview
      • Table F. Hoffmann-La Roche Ltd. - Business segments
      • Table F. Hoffmann-La Roche Ltd. - Organizational developments
      • Table F. Hoffmann-La Roche Ltd. - Geographic focus
      • Table F. Hoffmann-La Roche Ltd. - Segment focus
      • Table F. Hoffmann-La Roche Ltd. - Key offerings
      • Table F. Hoffmann-La Roche Ltd. - Key customers
    • Merck & Co. Inc.
      • Table Merck & Co. Inc. - Vendor overview
      • Table Merck & Co. Inc. - Business segments
      • Table Merck & Co. Inc. - Organizational developments
      • Table Merck & Co. Inc. - Geographic focus
      • Table Merck & Co. Inc. - Segment focus
      • Table Merck & Co. Inc. - Key offerings
      • Table Merck & Co. Inc. - Key customers
    • Pfizer Inc.
      • Table Pfizer Inc. - Vendor overview
      • Table Pfizer Inc. - Business segments
      • Table Pfizer Inc. - Organizational developments
      • Table Pfizer Inc. - Geographic focus
      • Table Pfizer Inc. - Segment focus
      • Table Pfizer Inc. - Key offerings
      • Table Pfizer Inc. - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
    • Definition of market positioning of vendors
      • Table Definition of market positioning of vendors
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report